FR2455585A1 - Derives d'oxoaminoacides, procede de fabrication et composition pharmaceutique - Google Patents

Derives d'oxoaminoacides, procede de fabrication et composition pharmaceutique

Info

Publication number
FR2455585A1
FR2455585A1 FR8009787A FR8009787A FR2455585A1 FR 2455585 A1 FR2455585 A1 FR 2455585A1 FR 8009787 A FR8009787 A FR 8009787A FR 8009787 A FR8009787 A FR 8009787A FR 2455585 A1 FR2455585 A1 FR 2455585A1
Authority
FR
France
Prior art keywords
oxoaminoacid
derivatives
manufacturing
pharmaceutical composition
single bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8009787A
Other languages
English (en)
Inventor
Masaki Toda
Katsuhiro Imaki
Shigeru Sakuyama
Takanori Okada
Masaki Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5423979A external-priority patent/JPS55147257A/ja
Priority claimed from JP9320579A external-priority patent/JPS5618959A/ja
Priority claimed from JP9489079A external-priority patent/JPS5620579A/ja
Priority claimed from JP12882679A external-priority patent/JPS5653670A/ja
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP9692080A priority Critical patent/JPS5724359A/ja
Publication of FR2455585A1 publication Critical patent/FR2455585A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom

Abstract

DERIVE D'OXOAMINOACIDE REPONDANT A LA FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE A EST UNE SIMPLE LIAISON, OU -CH-, -CH-CH-, CHCH, B EST UNE SIMPLE LIAISON OU -CH-, X EST -CH- OU UN ATOME O OU S, OU UN GROUPE NR, R EST H, OU UN ALKYLE INFERIEUR, R EST H OU UN ALCANOYLE INFERIEUR OU UN BENZOYLE, R EST H, UN ALKYLE INFERIEUR EVENTUELLEMENT SUBSTITUE. APPLICATION COMME MEDICAMENT POUR LE TRAITEMENT DE L'HYPERTENSION.
FR8009787A 1979-05-04 1980-04-30 Derives d'oxoaminoacides, procede de fabrication et composition pharmaceutique Pending FR2455585A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9692080A JPS5724359A (en) 1980-04-30 1980-07-17 Preparation of cyclic imide

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP5423979A JPS55147257A (en) 1979-05-04 1979-05-04 Pyroglutamic acid derivative, its preparation and pharmaceutical composition containing it as effective component
JP9320579A JPS5618959A (en) 1979-07-24 1979-07-24 4-oxoproline derivative, its preparation, and pharmaceutical composition containing the same
JP9489079A JPS5620579A (en) 1979-07-27 1979-07-27 2-oxazolidone-4-carboxylic acid derivative, its preparation, and drug composition comprising the same as active constituent
JP12882679A JPS5653670A (en) 1979-10-08 1979-10-08 2-oxothiazolidine-4-carboxylic acid derivative, its preparation, and pharmaceutical composition containing said compound as effective component

Publications (1)

Publication Number Publication Date
FR2455585A1 true FR2455585A1 (fr) 1980-11-28

Family

ID=27463028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8009787A Pending FR2455585A1 (fr) 1979-05-04 1980-04-30 Derives d'oxoaminoacides, procede de fabrication et composition pharmaceutique

Country Status (4)

Country Link
DE (1) DE3016960A1 (fr)
FR (1) FR2455585A1 (fr)
GB (1) GB2051781B (fr)
IT (1) IT8048579A0 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5788165A (en) * 1980-11-21 1982-06-01 Tanabe Seiyaku Co Ltd 2-oxoimidazolidine-4-carboxylic acid derivative and its preparation
EP0187037A3 (fr) * 1984-12-21 1988-03-23 Takeda Chemical Industries, Ltd. Dérivés de pipéridine, leur production et emploi

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4129566A (en) * 1978-02-15 1978-12-12 E. R. Squibb & Sons, Inc. Derivatives of dehydrocyclicimino acids
LU82023A1 (de) * 1978-12-22 1980-04-23 Squibb & Sons Inc Ketal-und thioketalderivate von mercaptoacylprolinen und-pipecolinsaeuren,verfahren zu ihrer herstellung und ihre verwendung zur behandlung von hochdruck

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4129566A (en) * 1978-02-15 1978-12-12 E. R. Squibb & Sons, Inc. Derivatives of dehydrocyclicimino acids
LU82023A1 (de) * 1978-12-22 1980-04-23 Squibb & Sons Inc Ketal-und thioketalderivate von mercaptoacylprolinen und-pipecolinsaeuren,verfahren zu ihrer herstellung und ihre verwendung zur behandlung von hochdruck

Also Published As

Publication number Publication date
GB2051781B (en) 1983-03-09
GB2051781A (en) 1981-01-21
IT8048579A0 (it) 1980-05-05
DE3016960A1 (de) 1980-11-13

Similar Documents

Publication Publication Date Title
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2377418A1 (fr) Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
TNSN87086A1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
NO152902C (no) Analogifremgangsmaae for fremstilling av terapeutisk virksomme 1-alkyl-2-aminotetralinderivater
FR2362834A1 (fr) Nouveaux derives 6-hemicetal ou 6-ceto de prostaglandine, leur procede de preparation et medicament les contenant
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
FR2364213A1 (fr) Nouveaux acides 5-alkoxyimidazo(1,2-a) quinoleine-2-carboxyliques et leurs derives et composition pharmaceutique les contenant
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
FR2449092A1 (fr) Derives de 7-oxo-4-thia-1-aza-bicyclo-(3,2,0)-heptane, procede pour les preparer et leur application comme medicaments
SE8600632D0 (sv) Novel pharmaceutical composition
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
FR2377419A1 (fr) Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2453151A1 (fr) Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
FR2355797A1 (fr) Procede de preparation de vinylcyclopropanes substitues utilisables dans la preparation d'insecticides
FR2445328A1 (fr) Derives du 14-oxo-e-homo-eburnane, leur procede de preparation et leur utilisation comme medicament
ES475361A1 (es) Procedimiento para preparar un nuevo derivado de piridina
FR2455585A1 (fr) Derives d'oxoaminoacides, procede de fabrication et composition pharmaceutique
FR2370020A2 (fr) Procede de preparation d'alkylphenols
KR890012942A (ko) 5-치환된 오르니틴 유도체
FR2386547A1 (fr) Nouveaux derives de la pyrido-(2,3-b)benzothiazepine-(1,5) substitues en position 5, leur procede de preparation et leur application pharmaceutique
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique